pillbase.ru

Moexipril Hydrochloride

Active substance: moexipril

TABLET, FILM COATED · MOEXIPRIL HYDROCHLORIDE 15 mg/1

United StatesActive

Marketing holder: Teva Pharmaceuticals USA, Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 3
  • Моэкс® 15
    таблетки покрытые оболочкой, 15 мг (original in Russian, GRLS)
    П N012699/01
    Шварц Фарма АГ
  • Моэкс® 7.5
    таблетки покрытые оболочкой, 7.5 мг (original in Russian, GRLS)
    П N012701/01
    Шварц Фарма АГ
  • Моэкс® плюс
    таблетки покрытые оболочкой, ~ (original in Russian, GRLS)
    ЛС-001476
    Шварц Фарма АГ
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c5-8133-71c0-a3df-eebd966ec924,01a120c5-813a-7c2f-8ecc-cec8d92702c6;count=2 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-fc74-75f7-af1a-2679a9524421,01a12090-1c1d-7823-ac3e-145178df35cf,01a12092-621a-7cbb-81ea-90287aa48235,01a12093-4856-7180-a967-2ee2d10ff632,01a12096-9b7c-752b-bb51-3bff5da3f850;count=6 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
0093-5150
Registration status
Active
Dispensing
Prescription only
Route
ORAL
Sources
  • product · openFDA NDC · 0093-5150 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 0093-5150 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 0093-5150 · Verified 2026-10-09 · open in source